Summary The influence of photodynamic therapy (PDT) on vascular perfusion and the development of hypoxia was investigated in the murine RIF-I tumour. Image analysis was used to quantify changes in perfusion and hypoxia at 5 min after interstitial Photofrin-mediated PDT. The fluorescent stain Hoechst 33342 was used as an in vivo marker of functional vascular perfusion and the antibody anti-collagen type IV as a marker of the tumour vasculature. The percentage of total tumour vasculature that was perfused decreased to less than 30% of control values after PDT. For the lower light doses this decrease was more pronounced in the centre of the tumour. The observed reduction in vascular perfusion showed a good linear correlation (r = 0.98) with previously published tumour perfusion data obtained with the 86Rb extraction technique. The image analysis technique provides extra information concerning the localisation of (non)-perfused vessels. To detect hypoxic tumour areas in vivo, an immunohistochemical method was used employing NITP [7-(4'-(2-nitroimidazol-l-yl)-butyl)-theophylline]. A large increase in hypoxic areas was found for PDT-treated tumours. More than half the total tumour area was hypoxic after PDT, compared with <4% for control tumours. Our studies illustrate the potential of image analysis systems for monitoring the functional consequences of PDTmediated vascular damage early after treatment. This provides direct confirmation that the perfusion changes lead to tissue hypoxia, which has implications for the combined treatment of PDT with bioreductive drugs.
The three-dimensional growth of solid tumours requires a vascular network of new capillaries. These new capillaries lack a supporting architecture and are thin-walled and leaky. The lack of a smooth muscle wall also renders them less responsive to vasoactive stimuli and more prone to compression, especially in larger tumours in which the interstitial pressure is raised. Thus, a tumour often has oxygen diffusion gradients and a relatively poor nutrient supply, which may result in areas of necrosis (Trotter et al., 1989; Vaupel et al., 1989; Folkman, 1993) . There is a close relationship between the width of the viable cell rim around the vessels and the distance that oxygen diffuses through the tumour. In certain tumour types, small areas of necrosis are seen between the blood vessels, i.e. a corded tumour structure (Thomlinson and Gray, 1955) . Central necrosis is also a common feature of larger tumours. Cells under extremely low Po2 values are likely to exist close to the areas of necrosis.
These areas of chronic hypoxia are the result of oxygen diffusion limitations. Transient, acute hypoxia has also been demonstrated in tumours (Trotter et al., 1989) . This is a perfusion-limited lypoxia that is caused by a temporary interruption of blood flow within the vasculature as the vessels undergo spontaneous opening and closing. Both chronic and acute mechanisms are responsible for the presence of hypoxic cells in tumours .
The percentage of hypoxic cells in a tumour may alter during therapy as previously hypoxic cells reoxygenate or new areas become hypoxic. Simple, rapid tests for the presence of hypoxic cells in tumours (e.g. Hirsch et al., 1987; Hodgkiss et al., 1991) could enable therapies like radiotherapy and photodynamic therapy (PDT) to be optimised on the basis of the oxygen status of the tumours. The hypoxic marker NITP [7-(4'-(2-nitroimidazol-1-yl)-butyl)-theophylline] (Hodgkiss et al., 1991) detects the presence of severely hypoxic cells, since nitroimidazoles are reduced in vitro at low oxygen levels, with K values of 0.02 -0.2% oxygen (oxygen level required for half-maximum sensitivity) depending on cell line and compound (Taylor and Rauth, 1982; Mulcahy, 1984; Hodgkiss et al., 1991) . Hypoxia represents a potential disadvantage to tumour cell killing by PDT, since fully hypoxic cells are completely resistant to this treatment; K values of 0.5 1-% oxygen have been determined for PDT cell killing in vitro (Henderson and Fingar, 1987; Chapman et al., 1991 a) . Consequently even if all the oxygenated cells of a tumour are killed by PDT, a hypoxic subpopulation could survive and allow the tumour to regrow. Severe PDT-induced vascular damage, which results in oxygen and nutrient deprivation, does, however, lead to secondary tumour cell death of these hypoxic cells (Henderson et al., 1985) . An understanding of the oxygen status of the tumour before and after PDT is very important for optimising treatment schedules, particularly if PDT is to be combined with bioreductive drugs. Intervention with bioreductive drugs could potentially increase the killing of naturally occurring hypoxic tumour cells or cells rendered hypoxic by PDT (Gonzalez et al., 1986; Bremner et al., 1992; Baas et al., 1994) . Hypoxia can occur even before the development of PDT-induced vascular damage. The photochemical processes involved in PDT consume oxygen very rapidly and oxygen depletion can occur during continuous illumination, particularly at high fluence rates (Foster et al., 1991) .
The purpose of this study was to analyse the patterns of vascularisation and hypoxic areas simultaneously in the RIF-1 tumour before and after PDT and to examine the influence of PDT on vascular perfusion and oxygen status in the tumour. The morphology of the vasculature was visualised with an antibody directed against the basal lamina of the blood vessels and areas of functional perfusion were identified with Hoechst 33342. For identifying the hypoxic areas in the tumour, the immunologically detectable hapten theophylline was used, covalently bound to a 2-nitroimidazole (NITP). 86RbCl extraction of estimates of vascular perfusion Vascular perfusion relative to the cardiac output was measured using the 86RbCI extraction technique as described previously (van Geel et al., 1994) . These results have been previously reported but are included here for comparison with the image analysis estimates of perfusion.
Staining of perfused vessels
The perfusion marker Hoechst 33342 (Aldrich, Milwaukee, WI, USA) was dissolved in sterile saline immediately before use. Mice were injected i.v. via one of the lateral tail veins with 0.1 ml Hoechst (at a concentration of 9 mg ml-') 5 min after illumination. Mice were killed by cervical dislocation 1 min after injection to prevent diffusion of Hoechst 33342 into adjacent non-perfused vascular structures. Thus, Hoechst specifically labels the nuclei of endothelial cells and nuclei of the cells adjacent to the vessel walls, thereby delineating the perfused vessels. The tumours were excised and frozen in liquid nitrogen before storing at -70°C until they were sectioned.
Frozen sections were taken from three levels (periphery, centre and contralateral periphery; three sections each) of each tumour. As a marker of the basal lamina of the tumour microvasculature, an antibody against the basal lamina component collagen IV was used (rabbit polyclonal antibody against collagen type IV, Eurodiagnostics BV, Oss, The Netherlands) as described by Bernsen et al. (1995) . Briefly, sections were air dried and fixed in acetone for 10 min.
Subsequently they were washed in phosphate-buffered saline (PBS) for 10 min. Sections were incubated with the antibody to collagen IV (1: 50 dilution in PBS containing 10% normal goat serum) for 45 min. After washing in PBS, the second antibody (goat anti-rabbit TRITC conjugated: Tago, Burlingame, USA) was applied at a dilution of 1: 25 in PBS containing 10% normal goat serum. The vascular pattern of RIF-I tumours was visualised with a fluorescence microscope (Axioshop, Zeiss) with 510-560 nm excitation and 590 nm emission filters showing red fluorescence. Hoechst 33342 could be studied under ultraviolet illumination showing blue fluorescence (excitation at 365 nm and emission at 420 nm) in the same sections.
Staining of hypoxic areas
The hypoxic marker NITP (supplied by Dr Hodgkiss) was dissolved in peanut oil (Sigma, St Louis, MO, USA) containing 10% dimethyl sulphoxide (DMSO) and injected i.p. in a volume of 0.27 ml for a 25 g mouse (0.5 mmol kg-'). Animals were injected 30 min before illumination and killed by cervical dislocation 120 min after administration of the drug. At this time, immunohistochemical detection of the bound theophylline groups in mouse tumours has been shown to be optimal (Hodgkiss et al., 1991) . Previous results had demonstrated no significant difference in vascular perfusion determined (by 86Rb extraction) at 5 min or 2 h after PDT of RIF-I tumours (van Geel et al., 1994) . Freshly excised tumours were frozen immediately in liquid nitrogen and stored at -70°C until they were sectioned. The method described by Hodgkiss et al. (1991) , with minor modifications, was used to stain hypoxic areas. Frozen sections were air dried and fixed in cold acetone. Non-specific sites were blocked with 0.5% normal goat serum in PBS. A rabbit antitheophylline antibody (Sigma), diluted 1: 2 in PBS, was applied and the sections incubated for 1 h. Pilot studies indicated that the best results were obtained with this dilution. After washing in PBS the sections were incubated for 1 h with a second biotinylated antibody (1:100). Subsequently, avidin alkaline phosphatase (Sigma) was added and the sections were incubated for 45 min. After final washings with PBS the enzyme substrate (containing 0.04% 4-nitro-blue tetrazolium chloridie + 0.02% 5-bromo-4-chloro-3-indolyl phosphate + 0.8% dimethylformamide in 0.1 mM Tris/HCl buffer pH 9.5+50 mM magnesium chloride + 0.1 M sodium chloride) was added, resulting in a red purple staining of the hypoxic areas (Coco Martin et al., 1992) .
Image analysis Whole tumour sections were automatically scanned using a digital image processing system to quantitate tumour vascular area and percentage of perfused vessels (after staining of sections for collagen and in vivo Hoechst injection respectively). The digital imaging procedure is described in detail by Rijken et al. (1995) . Briefly, the tumour sections were scanned twice on the computer-controlled motorised stage (Marzhauzer, Wetzlar, Germany) of a fluorescence microscope (Zeiss, Oberkochen, Germany), using two different filters (Hoechst and TRITC detection) and an intensified solid state camera (MXRi: HCS, Eindhoven, The Netherlands). Major artifacts such as air bubbles and mechanically damaged areas were excluded from analysis. Each image was processed to detect the stained structures using the following processing operations: image reduction, shading correction, object isolation from the background using a previously determined threshold. Per tumour section, new threshold values could be determined interactively before scanning the section if intensity differences between sections occurred. After processing all fields of each scan (field size; 1.22 mm2, 10 x objective: digital imaging application TCL-image, TNO, Delft, The Netherlands) the scanned area was reconstructed into one large image. were considered significant.
Results

Vascular perfusion
The mean relative vascular area (RVA) as determined by image analysis varied from 4 to 12% for control (untreated, Photofrin or light alone) and treated tumours (see Table I ). Within the same tumour the mean RVA was generally fairly homogeneous through the central and peripheral part of the tumour (Figure 2a and b) , although the periphery was slightly, but not significantly, better vascularised than the centre of the tumour after light alone. No significant difference was found between the mean RVA of the untreated control group and all the other groups (drug alone, light alone or PDT).
The mean relative perfused total area (RPTA) of untreated control tumours was 3.0 + 1.1%. There was a reduction after Photofrin or light alone (2.2+0.3% and 1.5% +0.2% respectively) which was most marked in central areas of tumours treated with light alone, probably caused by fibre insertion (Table I ). The 86Rb extraction technique (separate tumours) also demonstrated a small, but significant decrease in blood flow of tumours treated with fibre or light alone (van Geel et al., 1994) . PDT with 200 J cm-' caused a further reduction in relative perfused tumour area to 0.7+0.3%; the perfusion fraction (PF) in these tumours was homogeneous throughout the whole tumour. Previous studies had demonstrated that Photofrin-mediated PDT with 200 J cm-' resulted in a tumour regrowth time (to 2 mm larger than treatment size) of 16.0+0.9 days compared to 2.8+0.1 days for untreated controls; no cures were found with this light dose (van Geel et al., 1995a,b) . Tumours treated with PDT at lower light doses (30-60 J cm-') also had reduced RPTA, which was most evident in the central parts of the tumour (Figure 2b ). After these lower light doses the tumours all regrew in less than 8 days (van Geel et al., 1995b) .
PDT caused a dose-dependent reduction in tumour perfusion (Figure 3 
Hypoxic areas
The relative hypoxic area (RHA) (acute and chronic), including the necrotic areas was quantified by image analysis. Alkaline phosphatase visualisation of the theophylline tag in frozen sections of the control tumours showed a very low background staining of unbound metabolites of NITP (Figure 5a ; Table I ). The RHA in a 5 mm untreated RIF-l tumour was 3.5+0.2%. No significant difference was Figure 4 Correlation between vascular perfusion measured 5 min after PDT by the image technique and g6Rb technique (van Geel et al., 1994) . The correlation coefficient between the two techniques is 0.98.
found between the control groups but PDT clearly increased the hypoxic fraction ( Figure 5b ; Table I ). There was a light dose-dependent increase in hypoxic areas at 5 min after PDT, with a corresponding dose-related decrease in vascular perfusion (Figure 3 ). (Henderson et al., 1985; Star et al., 1986; Chapman et al., 1991b) Occasionally, immunohistochemical staining of hypoxic tumour areas was seen adjacent to the blood vessels. This may represent an example of acute hypoxia in which the blood flow has become temporarily disrupted at a time when the drug was available in the tumour cells for bioreductive metabolism. The duration of hypoxia was not measured in this study, however previous experiments indicated that blood flow was decreased for at least 24 h after PDT (van Geel et al., 1994) . The K value for radiobiological hypoxia is 0.4-0.5% (Begg et al., 1985; Hall, 1994 (Marshall and Rauth, 1986; Koch, 1993) . Thus, PDT should decrease the oxygen concentration in the tumour to below these levels to get an optimal effect from the combination of PDT and bioreductive drugs.
The image analysis study reported here visualised and quantified a significant decrease in vascular perfusion after PDT with a concomitant increase in hypoxic areas in the RIF-1 tumour. These results lend support to the proposals for the combined use of PDT and bioreductive drugs to exploit the PDT-induced hypoxia.
